ArticleNPJ digital medicine2026
Mapping AI startup investment and innovation in healthcare using a five-tier AI systems complexity framework.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial Intelligence (AI) is reshaping healthcare through advances in diagnostics, treatment, and operations, yet the startup ecosystem driving this transformation remains underexplored. Analyzing 3,807 AI health startups founded between 2010 and 2024, this study applies a five-tier framework of AI systems complexity to classify ventures by medical domain, AI systems level, funding, geography, and team composition. Nearly two-thirds of AI investments focus on clinical decision support, drug discovery, and diagnostics, domains associated with higher-complexity deep-learning systems, while areas such as mental health, public health, and rehabilitation attract less AI venture capital, reflecting scalability and data limitations rather than a lack of need. Startups remain concentrated in high-income countries, and founding teams are predominantly technical and business-oriented, with limited clinical representation and gender diversity. By linking these empirical patterns to the five-tier framework, we show how AI systems complexity shapes innovation pathways, offering a foundation for more equitable, evidence-driven digital-medicine ecosystems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.